Delix Therapeutics
Executivos
Veja o organograma con seus 13 executivos principais
Biografias mais buscadas da Delix Therapeutics
Criar um alerta
para seguir os movimentos de executivos da Delix Therapeutics.
Biotecnologia
Delix Therapeutics possui 2.297 concorrentes concorrentes Lonza (Suíça), Eurofins (Luxemburgo) e Adaptive Phage Therapeutics (Estados Unidos).
Popular M&A news in Biotecnologia
- Johnson & Johnson has announced the acquisition of Proteologix (publicado em 20 de maio de 2024).
- Rapport Therapeutics acaba de anunciar uma arrecadação de fundos de 100 milhões de dólares. (publicado em 20 de maio de 2024).
- Lycia Therapeutics acaba de anunciar uma arrecadação de fundos de 107 milhões de dólares. (publicado em 15 de maio de 2024).
Outros contatos sugeridos na indústria do Biotecnologia
Notícias
Últimos comunicados de imprensa de Delix Therapeutics
- https://www.delixtherapeutics.com/news/delix-therapeutics-awarded-national-institutes-of-health-grant-to-advance-vital-research-of-novel-neuroplastogen-for-substance-use-disorders/
- https://www.delixtherapeutics.com/news/delix-presents-interim-data-from-phase-i-trial-of-novel-neuroplastogen-at-acnp-annual-meeting/
- https://www.delixtherapeutics.com/news/the-future-of-psychedelic-medicine-will-be-drugs-youve-never-heard-of/
- https://www.delixtherapeutics.com/news/delix-therapeutics-closes-30-million-convertible-note-financing-enters-10-million-strategic-credit-facility-option-in-partnership-with-comerica-bank/
- https://www.delixtherapeutics.com/news/drug-companies-are-investing-big-in-psychedelics-but-can-they-engineer-out-the-trip/
- Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability
- Pioneering Delix Therapeutics Study Published in 'Science' Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity
- The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
- The Galien Foundation Announces 2023 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
- Delix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001
- View more press releases Close
Redes sociais sobre Delix Therapeutics
- Delix Therapeutics na Wikipedia, Google News e Yahoo Finance
- Delix Therapeutics na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Nick Haft 
Ligue para a Delix Therapeutics em +1 832...
